Cargando…
Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial
OBJECTIVE: This study evaluated subcutaneous injections of tetrodotoxin (TTX) for the treatment of moderate to severe, inadequately controlled cancer-related pain. METHODS: Eligible patients were randomized to receive TTX (30 μg) or placebo subcutaneously twice daily for four consecutive days. Effic...
Autores principales: | Hagen, Neil A., Cantin, Lyne, Constant, John, Haller, Tina, Blaise, Gilbert, Ong-Lam, May, du Souich, Patrick, Korz, Walter, Lapointe, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438848/ https://www.ncbi.nlm.nih.gov/pubmed/28555092 http://dx.doi.org/10.1155/2017/7212713 |
Ejemplares similares
-
Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial
por: Goldlust, Samuel A., et al.
Publicado: (2021) -
Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy Adults
por: Kavoosi, Mojgan, et al.
Publicado: (2020) -
The Acute Toxicity of Tetrodotoxin and Tetrodotoxin–Saxitoxin Mixtures to Mice by Various Routes of Administration
por: Finch, Sarah C., et al.
Publicado: (2018) -
Tetrodotoxin —A brief history—
por: NARAHASHI, Toshio
Publicado: (2008) -
Addressing the Issue of Tetrodotoxin Targeting
por: Melnikova, Daria I., et al.
Publicado: (2018)